Bridgefront Capital’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$220K Sell
2025
Q2
$332K Sell
2025
Q1
$616K Buy
2022
Q3
Sell
2022
Q2
$61K Sell
2022
Q1
$105K Buy
2021
Q3
Sell
2021
Q2
$144K Buy